Caprius to add three joint ventures
Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based company’s Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration
Breast MRI developer Caprius has received three letters of intent for joint ventures utilizing the Wilmington, MA-based companys Aurora scanner, which is the only dedicated MRI breast imaging system to have received Food and Drug Administration 510(k) clearance. The joint ventures partners would be located in New York City, Columbus, OH, and Knoxville, TN, and would be similar to other joint ventures currently in operation in sites such as Magee Womens Hospital and Englewood Hospital and Medical Center, according to Caprius.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
